Pandha, Hardev and Morgan, Richard ORCID: https://orcid.org/0000-0002-8721-4479 (2020) PBX3 in cancer. Cancers, 12 (2). p. 431. ISSN 2072-6694

Preview

PDF PBX3 in cancer 2020.pdf - Published Version Available under License Creative Commons Attribution. Download (363kB) | Preview

Abstract

PBX3 is a homeodomain-containing transcription factor of the pre-B cell leukemia (PBX) family, members of which have extensive roles in early development and some adult processes. A number of features distinguish PBX3 from other PBX proteins, including the ability to form specific and stable interactions with DNA in the absence of cofactors. PBX3 has frequently been reported as having a role in the development and maintenance of a malignant phenotype, and high levels of PBX3 tumor expression have been linked to shorter overall survival in cancer. In this review we consider the similarities and differences in the function of PBX3 in different cancer types and draw together the core signaling pathways involved to help provide a better insight into its potential as a
therapeutic target.

Item Type:	Article
Identifier:	10.3390/cancers12020431
Keywords:	PBX3; PBX; HOX; microRNA; acute myeloid leukemia; gastric cancer; colorectal cancer; liver cancer
Subjects:	Medicine and health
Related URLs:	Publisher Publisher
Depositing User:	Richard Morgan
Date Deposited:	08 Jul 2020 08:26
Last Modified:	04 Nov 2024 11:48
URI:	https://repository.uwl.ac.uk/id/eprint/7095

Downloads

Actions (login required)

View Item